Abstract
In the present chapter, several clinical hemodiafiltration (HDF) studies are discussed, with special emphasis on the reliability of the methodology used. These studies differ widely in design, end points, patient numbers, treatment and comparator groups, and amount of convection volume in the treatment arms. Recently, three large randomized controlled trials (RCT) have been performed comparing survival between online postdilution HDF and hemodialysis (HD). While neither CONTRAST nor the Turkish HDF study showed differences between study arms, in the Spanish ESHOL study the mortality risk was significantly lower in HDF patients (HR 0.70; 95 % CI 0.53–0.92). In all three studies, post-hoc (on-treatment) analysis showed a survival benefit up to 40 % for patients treated with high-volume HDF (convection volume >20–22 L/treatment). Apart from these RCTs, in the last 4 years five meta-analyses on convective therapies have been performed, including four on aggregated study results and one on pooled individual patient data (IPD). Since in the latter approach all individual patient data from trials are ascertained, put together and combined to a new data base, this type of meta-analysis is most reliable for making adjustments and evaluating subgroup results. Notably, in both types of meta-analyses the hazard ratio (HR) for mortality of online HDF (as compared to HD) was about 0.83–0.86, indicating a 15 % lower mortality risk for patients treated with HDF. From the IPD meta-analysis it appeared that the mortality risk was even lower when high convection volumes are applied (HR 0.78; 95 % CI 0.62–0.98). Finally, meta-analysis on modern convective therapies should include only online treatments with a convection volume >20 L/session.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Henderson LW, Colton CK, Ford CA. Kinetics of hemodiafiltration. II. Clinical characterization of a new blood cleansing modality. J Lab Clin Med. 1975;85(3):372–91.
Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney Int. 1999;55(1):286–93.
Jirka T, Cesare S, Di BA, Perera CM, Ponce P, Richards N, et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis. Kidney Int. 2006;70(8):1524–5.
Canaud B, Bragg-Gresham JL, Marshall MR, Desmeules S, Gillespie BW, Depner T, et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS. Kidney Int. 2006;69(11):2087–93.
Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, et al. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study. Nephrol Dial Transplant. 2008;23(7):2337–43.
Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K. Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clin J Am Soc Nephrol. 2009;4(12):1944–53.
Imamovic G, Hrvacevic R, Kapun S, Marcelli D, Bayh I, Grassmann A, et al. Survival of incident patients on high-volume online hemodiafiltration compared to low-volume online hemodiafiltration and high-flux hemodialysis. Int Urol Nephrol. 2014;46(6):1191–200.
Siriopol D, Canaud B, Stuard S, Mircescu G, Nistor I, Covic A. New insights into the effect of haemodiafiltration on mortality: the Romanian experience. Nephrol Dial Transplant. 2015;30(2):294–301.
Canaud B, Bayh I, Marcelli D, Ponce P, Merello JI, Gurevich K, et al. Improved survival of incident patients with high-volume haemodiafiltration: a propensity-matched cohort study with inverse probability of censoring weighting. Nephron. 2015;129(3):179–88.
Canaud B, Barbieri C, Marcelli D, Bellocchio F, Bowry S, Mari F, et al. Optimal convection volume for improving patient outcomes in an international incident dialysis cohort treated with online hemodiafiltration. Kidney Int. 2015. doi.10.1038/ki.2015.139. (Epub ahead of print)
Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney Int. 1996;50(4):1293–302.
Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol. 2000;11(12):2344–50.
Wizemann V, Lotz C, Techert F, Uthoff S. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrol Dial Transplant. 2000;15 Suppl 1:43–8.
Locatelli F, Altieri P, Andrulli S, Bolasco P, Sau G, Pedrini LA, et al. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. J Am Soc Nephrol. 2010;21(10):1798–807.
Tessitore N, Santoro A, Panzetta GO, Wizemann V, Perez-Garcia R, Martinez AJ, et al. Acetate-free biofiltration reduces intradialytic hypotension: a European multicenter randomized controlled trial. Blood Purif. 2012;34(3–4):354–63.
Canaud B, Morena M, Leray-Moragues H, Chalabi L, Cristol JP. Overview of clinical studies in hemodiafiltration: what do we need now? Hemodial Int. 2006;10 Suppl 1:S5–12.
Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol. 2012;23(6):1087–96.
Ok E, Asci G, Toz H, Ok ES, Kircelli F, Yilmaz M, et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant. 2013;28(1):192–202.
Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Carreras J, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol. 2013;24(3):487–97.
Rabindranath KS, Strippoli GF, Roderick P, Wallace SA, MacLeod AM, Daly C. Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review. Am J Kidney Dis. 2005;45(3):437–47.
Locatelli F. Comparison of hemodialysis, hemodiafiltration, and hemofiltration: systematic review or systematic error? Am J Kidney Dis. 2005;46(4):787–8.
Susantitaphong P, Siribamrungwong M, Jaber BL. Convective therapies versus low-flux hemodialysis for chronic kidney failure: a meta-analysis of randomized controlled trials. Nephrol Dial Transplant. 2013;28(11):2859–74.
Mostovaya IM, Blankestijn PJ, Bots ML, Covic A, Davenport A, Grooteman MP, et al. Clinical evidence on hemodiafiltration: a systematic review and a meta-analysis. Semin Dial. 2014;27(2):119–27.
Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, et al. Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials. Am J Kidney Dis. 2014;63(6):954–67.
Grooteman MP, Blankestijn PJ, Nube MJ. Not all convective dialysis therapies are equal. Am J Kidney Dis. 2014;64(5):819–20.
Wang AY, Ninomiya T, Al-Kahwa A, Perkovic V, Gallagher MP, Hawley C, et al. Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials. Am J Kidney Dis. 2014;63(6):968–78.
Susantitaphong P, Jaber BL. Understanding discordant meta-analyses of convective dialytic therapies for chronic kidney failure. Am J Kidney Dis. 2014;63(6):888–91.
Ronco C, Brendolan A, Lupi A, Metry G, Levin NW. Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int. 2000;58(2):809–17.
Peters SAE, Bots ML, Canaud B, Davenport A, Grooteman MPC, Kircelli F, et al. Haemodiafiltration and mortality in end stage kidney disease patients. A pooled individual participant data meta-analysis from four randomized controlled trials. Nephrol Dial Transplant 2015. doi:10.1093/ndt/gfv349.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Grooteman, M.P.C., Nubé, M.J., Bots, M.L. (2016). Clinical Trials on Hemodiafiltration. In: Nubé, M., Grooteman, M., Blankestijn, P. (eds) Hemodiafiltration. Springer, Cham. https://doi.org/10.1007/978-3-319-23332-1_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-23332-1_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23331-4
Online ISBN: 978-3-319-23332-1
eBook Packages: MedicineMedicine (R0)